| [1] |
Horwitz SM, Zelenetz AD, Gordon LI, et al.
NCCN guidelines insights: non-Hodgkin's lymphomas, version 3.2016[J]. J Natl Compr Canc NetwJ Natl Compr Canc Netw, 2016, 14(9): 1067-1079.
doi: 10.6004/jnccn.2016.0117 |
| [2] |
Al-Mansour Z, Li HL, Cook JR, et al.
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis[J]. Leuk LymphomaLeuk Lymphoma, 2019, 60(8): 1934-1941.
doi: 10.1080/10428194.2018.1563691 |
| [3] |
Hamadani M, Hari PN, Zhang Y, et al.
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation[J]. Biol Blood Marrow TransplantBiol Blood Marrow Transplant, 2014, 20(11): 1729-1736.
doi: 10.1016/j.bbmt.2014.06.036 |
| [4] |
Cheson BD, Fisher RI, Barrington SF, et al.
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification[J]. J Clin OncolJ Clin Oncol, 2014, 32(27): 3059-3068.
doi: 10.1200/JCO.2013.54.8800 |
| [5] |
El-Galaly TC, Villa D, Gormsen LC, et al.
FDG-PET/CT in the management of lymphomas: current status and future directions[J]. J Intern MedJ Intern Med, 2018, 284(4): 358-376.
doi: 10.1111/joim.12813 |
| [6] |
Lamy T, Damaj G, Soubeyran P, et al.
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma[J]. BloodBlood, 2018, 131(2): 174-181.
doi: 10.1182/blood-2017-07-793984 |
| [7] |
汪太松, 乔文礼, 邢岩, 等.
中期18F-FDG PET/CT评估结外鼻型NK/T细胞淋巴瘤的预后价值[J]. 中国实验血液学杂志中国实验血液学杂志, 2021, 29(3): 731-734.
doi: 10.19746/j.cnki.issn1009-2137.2021.03.013 Wang TS, Qiao WL, Xing Y, et al. Prognostic value of interim 18F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type[J]. J Exp HematolJ Exp Hematol, 2021, 29(3): 731-734. doi: 10.19746/j.cnki.issn1009-2137.2021.03.013 |
| [8] |
Winter A, Rybicki L, Shah SN, et al.
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation[J]. Leuk LymphomaLeuk Lymphoma, 2018, 59(5): 1195-1201.
doi: 10.1080/10428194.2017.1369065 |
| [9] |
Ahn SY, Jung SY, Jung SH, et al.
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas[J]. Ann HematolAnn Hematol, 2020, 99(1): 83-91.
doi: 10.1007/s00277-019-03867-9 |
| [10] |
Ying ZT, Mi L, Wang XJ, et al.
Prognostic value of pre- and post-transplantation 18F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation[J]. Chin J Cancer ResChin J Cancer Res, 2017, 29(6): 561-571.
doi: 10.21147/j.issn.1000-9604.2017.06.11 |
| [11] |
Dai N, Zhou YY, Deng SM, et al.
Prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography after autologous hematopoietic stem cell transplantation in lymphoma using Deauville scores[J]. Contrast Media Mol ImagingContrast Media Mol Imaging, 2021, : 5510825-.
doi: 10.1155/2021/5510825 |
| [12] |
Younes A, Hilden P, Coiffier B, et al.
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)[J]. Ann OncolAnn Oncol, 2017, 28(7): 1436-1447.
doi: 10.1093/annonc/mdx097 |
| [13] |
Berzaczy D, Haug A, Staber PB, et al. RECIL versus Lugano for treatment response assessment in FDG-avid non-Hodgkin lymphomas: a head-to-head comparison in 54 patients[J/OL]. Cancers (Basel), 2019, 12(1): 9[2023-01-15]. https://www.mdpi.com/2072-6694/12/1/9. DOI: 10.3390/cancers12010009. |
| [14] |
Kostakoglu L, Davies A, Herold M, et al. Recil 2017 criteria demonstrated similar prognostic value and detected a comparable treatment difference between obinutuzumab- and rituximab-chemotherapy compared with Cheson 2007 and Lugano 2014 criteria in patients with previously untreated advanced-stage follicular lymphoma[J/OL]. Blood, 2020, 136(Suppl 1): S25−26 [2023-01-15]. https://doi.org/10.1182/blood-2020-134784. DOI: 10.1182/blood-2020-134784. |
| [15] |
Zheng XQ, Ding CY, Zou YX, et al.
Roles of PET/CT in predicting the prognosis of diffuse large B cell lymphoma patients treated with chimeric antigen receptor T cell therapy[J]. J Exp HematolJ Exp Hematol, 2020, 28(4): 1189-1196.
doi: 10.19746/j.cnki.issn1009-2137.2020.04.018 |
| [16] |
Sohn BS, Yoon DH, Kim KP, et al.
The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin's lymphoma patients[J]. Ann HematolAnn Hematol, 2013, 92(10): 1369-1377.
doi: 10.1007/s00277-013-1782-5 |
| [17] |
Stefani PM, Salvadori U, Gottardi M, et al.
Prognostic value of PET/CT in patients with lymphoma treated with autologous stem cell transplantation for relapsed/refractory or high risk disease[J]. Q J Nucl Med Mol ImagingQ J Nucl Med Mol Imaging, 2019, 63(1): 62-67.
doi: 10.23736/S1824-4785.17.02793-5 |
| [18] |
Armand P, Welch S, Kim HT, et al.
Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era[J]. Br J HaematolBr J Haematol, 2013, 160(5): 608-617.
doi: 10.1111/bjh.12176 |
| [19] |
戴娜, 邓胜明, 谈佳卿, 等.
自体造血干细胞移植前或后18F-FDG PET/CT显像对非霍奇金淋巴瘤的预后评估[J]. 中华核医学与分子影像杂志中华核医学与分子影像杂志, 2018, 38(2): 83-86.
doi: 10.3760/cma.j.issn.2095-2848.2018.02.002 Dai N, Deng SM, Tan JQ, et al. Predictive value of 18F-FDG PET/CT before or after autologous hematopoietic stem cell transplantation for the clinical outcome of patients with non-Hodgkin's lymphoma[J]. Chin J Nucl Med Mol ImagingChin J Nucl Med Mol Imaging, 2018, 38(2): 83-86. doi: 10.3760/cma.j.issn.2095-2848.2018.02.002 |
| [20] |
Palmer J, Goggins T, Broadwater G, et al.
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma[J]. Bone Marrow TransplantBone Marrow Transplant, 2011, 46(6): 847-851.
doi: 10.1038/bmt.2010.203 |
| [21] |
范丹, 刘强, 肖方, 等.
自体造血干细胞移植治疗弥漫大B细胞淋巴瘤患者的疗效分析[J]. 中国实验血液学杂志中国实验血液学杂志, 2021, 29(4): 1163-1168.
doi: 10.19746/j.cnki.issn1009-2137.2021.04.022 Fan D, Liu Q, Xiao F, et al. Clinical efficacy of autologous hematopoietic stem cell transplantation for patients with diffuse large B-cell lymphoma[J]. J Exp HematolJ Exp Hematol, 2021, 29(4): 1163-1168. doi: 10.19746/j.cnki.issn1009-2137.2021.04.022 |
| [22] |
Zhang XY, Song L, Wang PJ, et al.
Prognostic value of pre-autologous stem cell transplantation PET/CT in diffuse large B-cell lymphoma: the Deauville score is prognostically superior to ΔSUVmax[J]. Acta HaematolActa Haematol, 2020, 143(2): 124-130.
doi: 10.1159/000500512 |